CONFERENCE COVERAGE SERIES

Gladstone Workshop: ApoE4

San Francisco, California, U.S.A.

30 January 2012 – 01 February 2014

Tools

Back to the Top

Considering the dramatic impact of its E4 allelic variant on Alzheimer’s disease risk, apolipoprotein E arguably has drawn scant attention from AD drug developers. At a workshop organized by the Gladstone Institute of Neurological Disease in San Francisco, researchers focused in on what makes the protein so harmful.